Humoral response to BNT162b2 mRNA COVID‐19 vaccine in peritoneal and hemodialysis patients: A comparative study
Humoral response to BNT162b2 mRNA COVID‐19 vaccine in peritoneal and hemodialysis patients: A comparative study
R. Duarte,M. Roldão,5 Authors,K. Lopes
2021 · DOI: 10.1111/1744-9987.13766
medRxiv · 12 Citations
TLDR
This study aims to compare humoral response between hemodialysis and peritoneal dialysis patients with higher risk of exposure with increased mortality from COVID‐19.
Abstract
Maintenance dialysis patients (MDP) are at higher risk of exposure with increased mortality from COVID‐19 with generalized immunization becoming the cornerstone in prevention. This study aims to compare humoral response between hemodialysis (HD) and peritoneal dialysis (PD) patients.